Can clinical Subtypes of Hidradenitis Suppurativa lead to more individual treatment?

MEDtalk with Dorra Bouazzi, MD, Zealand University Hospital, who presents her poster from NCDV 2022, based on a global multicenter study with approximately 5,000 patients and 14 centers involved. The study suggest that clinical subtypes may exist, and this study try to classify HS patients into clinically meaningful subtypes, which can lead to more individual treatments.